Lifecore Biomedical
LFCR
LFCR
103 hedge funds and large institutions have $226M invested in Lifecore Biomedical in 2025 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 26 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 100 → 103 (+3)
1.16% more ownership
Funds ownership: 65.01% → 66.17% (+1.2%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
Holders
103
Holding in Top 10
5
Calls
$879K
Puts
$229K
Top Buyers
| 1 | +$862K | |
| 2 | +$679K | |
| 3 | +$612K | |
| 4 |
BlackRock
New York
|
+$492K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$454K |
Top Sellers
| 1 | -$900K | |
| 2 | -$360K | |
| 3 | -$299K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$282K |
| 5 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
-$278K |
